Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Program Grant
Funding Amount
Up to US $250,000
Deadline
Deadline not published
Grant Type
Foundation
Overview
Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Program
The HSR-ADRD program seeks to support research that strengthens dementia detection, diagnosis, and post-diagnostic care pathways along the care continuum. Projects may address a range of health services research questions, including, but not limited to, studies examining barriers and solutions to timely access, quality, and care coordination. By supporting rigorous and innovative research, this program aims to generate actionable evidence to improve person-centered, coordinated, and equitable brain health and dementia care.
Program overview
The program welcomes proposals that utilize rigorous methodologies to advance understanding and improvement of cognitive impairment, including MCI and Alzheimer’s disease and related dementias (AD/ADRD) detection, diagnosis, and post-diagnostic care.
This award is structured as an individual research grant, with funding administered through the recipient’s institution. Proposals should address one or more Areas of Focus. Areas of Focus represent high-priority research topics for which this program is actively seeking proposals and include:
The Value of Early Detection and Diagnosis: Studies should investigate outcomes associated with early detection and diagnosis on at least two levels of the dementia care ecosystem (i.e., individual/families, providers/clinicians, health systems/payers, and policy/society).Care Pathways for Individuals with MCI or Dementia: Studies should consider comorbidities and investigate how people are being screened and diagnosed in different settings, and the post-diagnosis pathways for care and treatment, including pharmacological and non-pharmacological interventions or combinations thereof.
Funding overview
Each HSR-ADRD award is limited to a total of $250,000 U.S. (direct and indirect costs) for a duration of up to two years (awards should be a minimum one year).Indirect costs are capped at 10 percent of total direct costs and are inclusive of indirect costs for the implementing institution as well as for any subcontracts.
What Alzheimer's Disease & Related Disorders Association Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 79
- Total given
- $73.3M
- Median grant
- $271K
- Range
- $10K–$13.29M
- By dollars: California 20%, Missouri 19%, Illinois 16%. Top recipient cities: Chicago, IL; New York, NY; Boston, MA.
- 0% of grants with a stated purpose were for general or operating support.
- 42% of recipients were new grantees, not repeat recipients.
Example grants
Washington University in St Louis · St Louis, MO
Program support
$13.29M
Alzheimer's Impact Movement · Chicago, IL
Program support
$10.59M
Wake Forest University Health Sciences · Winstonsalem, NC
Program support
$5.95M
The Regents of the University of California San Francisco · San Francisco, CA
Program support
$5.23M
University of Southern California (USC) · Los Angeles, CA
Program support
$3.18M
Focus Areas & Funding Uses
Fields of Work
- Alzheimer's
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 10, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $1,000,000
Deadline
May 7, 2028
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $1,500,000
Deadline
November 5, 2027
NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $400,000
Deadline
May 26, 2027
NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
May 26, 2027
Ready to apply for Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Program Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Program Grant. Now let's win it.